Yes, you saw it right. Almost $1B for a preclinica
Post# of 72433
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
B-UP is a lock to advance to Phase 2b. Cha-ching!
Quote:
J&J will pay Protagonist $125 million if it moves the drug into phase 2b and a further $200 million if it sticks with the asset after getting a look at data from the trial.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)